Metagenomi Therapeutics MGX
NASDAQ MGX
$1.12 -0.01 (-0.89%)
As of: Sep 30, 2026 · 12:38 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Assets (2023 - 2026)

Updated

Metagenomi Therapeutics' Assets came in at $173.7 million for Q2 2026, down 36.2% from $272.28 million a year earlier and down 11.8% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Metagenomi Therapeutics' Assets was $221.1 million, down 31.9% from FY2024.

  • Going back by year, Assets was $324.6 million in FY2024 (-11.0%) and $364.84 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Assets in data going back to Q4 2023.
  • Year-over-year, Assets has declined for seven consecutive quarters, with an average decline of 28.8% over the last seven quarters.
  • Business Quant data shows MGX's Assets at $196.95 million (Q1 2026), $221.1 million (Q4 2025) and $247.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 173.70 Mn
Mar 31, 2026 196.95 Mn
Dec 31, 2025 221.10 Mn
Sep 30, 2025 247.94 Mn
Jun 30, 2025 272.28 Mn
Mar 31, 2025 297.87 Mn
Dec 31, 2024 324.60 Mn
Sep 30, 2024 358.35 Mn
Jun 30, 2024 385.91 Mn
Mar 31, 2024 415.40 Mn
Dec 31, 2023 364.84 Mn
API Access

Metagenomi Therapeutics, Inc. Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=MGX&period=max&api_key=YOUR_API_KEY